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SUMMARY Porokeratosis is the common name of several 
diseases of unknown pathogenesis, which are similar in clinical 
appearance. It was first described in 1893 and was thought to 
be a disorder of sweat glands, hence the name porokeratosis. 
The lesion that can be found in all cases is annular, with atrophic 
center, and hyperkeratotic outer ring. Cases of porokeratosis have 
been linked with genetic heritage, excessive ultraviolet exposure, 
kidney failure, and state of immunosuppression, but no definitive 
link has been established. As a rare condition, its main feature 
is that the correct diagnosis can be delayed for a significant 
period of time. Porokeratotic lesions have a high incidence of 
malignant transformation and are considered premalignant. We 
present a case where a porokeratotic lesion was unsuccessfully 
treated as a psoriatic lesion for more than a year in a patient with 
previously diagnosed psoriasis. A skin biopsy was performed 
at our department, which revealed classic cornoid lamella 
and thus led to the correct diagnosis. The lesion was excised. 
Additional diagnostic tests revealed normal kidney function and 
intact immune system. A follow-up protocol was established for 
the patient, ensuring timely diagnosis of any future porokeratotic 
lesions. Porokeratosis, especially when there are only few lesions, 
is not difficult to manage – once it is diagnosed. A diagnosis of 
porokeratosis may also aid in identifying a serious systemic 
disease such as kidney failure. Importantly, a misdiagnosis of 
porokeratosis may lead to development of skin cancer.
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IntRodUCtIon
Porokeratosis is a group of disorders of kera-
tinization characterized by annular lesions with 
atrophic center and hyperkeratotic outer ring. The 
disorder was originally described in 1893 inde-
pendently by two authors, Mibelli and Respighi 
(1,2). The cause of porokeratosis is still unknown. 
However, nowadays this condition is considered 
a genodermatosis with an autosomal dominant 
mode of inheritance. In patients with genetic pre-
disposition, external triggering factors such as irra-
diation, infective agents, trauma, and immunosup-
pression can determine the activation of abnormal 
clone of epidermal keratinocytes (3-7). According 
to the published reports, porokeratotic lesions 
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undergo malignant alteration in around 10% of 
cases, usually in Bowen’s disease, planocellular 
or basal cell carcinoma (8). Accordingly, poro-
keratoses are considered a premalignant condi-
tion (9). This uncommon disease is characterized 
by annular, gyrate plaques with central atrophy 
and sharply elevated hyperkeratotic borders. Mi-
belli named this condition porokeratosis, believing 
that it involved the pores of the sweat ducts (3). 
Porokeratoses can only be diagnosed by skin bi-
opsy and histopathology. The latter would reveal 
a formation called cornoid lamella (10). Although 
cornoid lamella is not specific for porokeratosis, 
the diagnosis of porokeratosis cannot be estab-
lished without it. There are several forms of po-
rokeratosis: classic porokeratosis (porokeratosis 
of Mibelli), disseminated superficial actinic poro-
keratosis, disseminated superficial porokeratosis, 
linear porokeratosis, punctate porokeratosis, and 
porokeratosis palmaris et plantaris disseminata. 
The most common form is disseminated superfi-
cial actinic porokeratosis, which typically appears 
in elderly females. It is characterized by multiple 
small brown hyperkeratotic lesions, usually locat-
ed on the extensor surfaces of extremities. Classic 
porokeratosis of Mibelli is a rare disease, as are 
all other forms of porokeratosis, which appears 
primarily in young males. In classic porokeratosis, 
there is usually one or several lesions that can be 
located anywhere on the skin. Still, the most com-
mon sites of classic porokeratosis are the extremi-
ties. Despite the wide variety of clinical presenta-
tion of porokeratoses, the histopathologic, immu-
nohistochemical, and ultrastructural features are 
the same. Treatment of porokeratosis does not 
show encouraging results (10). Isolated or smaller 
lesions can be treated by excision, cryotherapy, 
or laser therapy (11,12). Topical treatment by 5-
fluorouracyl, tretinoin, diclofenac, imiquimod, and 
photodynamic therapy is sometimes successful 
(13-18). Systemic treatment by retinoids can lead 
to remission, but therapy discontinuation may lead 
to recurrence (19). Due to its rarity, porokeratoses 
are often misdiagnosed and treated unsuccess-
fully. Here we present a case where a single po-
rokeratotic lesion in an elderly male patient was 
treated as psoriasis for a year.
CASe RepoRt
A 68-year-old male patient was referred to our 
department because of a lesion in the nuchal re-
gion, first noticed a year before. During the last 
8 years, the patient had been treated for erythe-
ma-squamous lesions located on the elbows and 
dorsal sides of hands. These lesions were treated 
as psoriasis, with intermittent topical corticoids 
and keratolytic agents that led to regression. 
When the nuchal lesion was noticed, the same 
therapy was applied, without success (Fig. 1). The 
patient’s family history was negative for dermato-
logic diseases. He took therapy for hypertension 
and uric arthritis. Overall, he felt ‘healthy‘. When 
younger, he had been frequently exposed to sun-
light without adequate protection. On dermatologic 
examination, an erythematous solitary papule with 
atrophic central area was detected in the nuchal 
region, measuring 10x8 mm. Skin biopsy was per-
formed, with the excised part of the skin containing 
both peripheral and central area. Histopathology 
revealed multiple parakeratotic columns (cornoid 
lamella) within the epidermis. Underneath, in the 
upper malpighian layer, some of the keratinocytes 
appeared vacuolated and dyskeratotic. A moder-
ate focal lymphohistiocyte infiltrate and elastosis 
were observed in the upper dermis. Such a histo-
pathologic finding is the hallmark of classic poro-
keratosis of Mibelli (Fig. 2). As it was isolated le-
sion, complete excision was performed. Additional 
diagnostic tests were carried out to exclude the 
possible immune disorders or chronic renal fail-
ure, since porokeratosis may be linked with these 
conditions. The tests included complete and differ-
ential blood count, serum concentrations of urea 
and creatinine, and kidney ultrasound examina-
tion. All the tests came out negative. The patient 
was informed about the nature of porokeratosis. 
Strict sunlight protection was emphasized and a 
follow-up protocol was scheduled.
Figure 1. Porokeratotic lesion in the nuchal region, after 
biopsy. 
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dISCUSSIon
Porokeratosis is a rare disease, which is com-
monly misdiagnosed, most frequently as psoria-
sis (20). The frequent misdiagnosis reminds us 
of the potential danger of porokeratosis. On the 
one hand, the development or sudden flare-up of 
porokeratosis can be a sign of a serious condi-
tion, such as immunodeficiency or kidney failure 
(21-24). On the other hand, porokeratosis rep-
resents a form of clonal keratinocyte expansion 
with chromosomal instability, which in many cases 
undergoes malignant transformation to basal cell 
or spinocellular carcinoma. This emphasizes the 
necessity of long-term follow-up of patients with 
porokeratosis (9,25). However, the crucial ele-
ment of porokeratosis treatment is its recognition. 
In misdiagnosed cases, a life-threatening disease 
can develop unnoticed and porokeratosis can 
turn into carcinoma. Recognition of porokeratosis 
makes all the difference. The possible systemic 
disorders can easily be diagnosed using standard 
diagnostic procedures, and meticulous follow-up 
of porokeratotic lesions with biopsies and exci-
sions of suspect lesions can prevent uncontrolled 
malignant transformation. Patients must avoid UV 
exposure (without protection), use of tanning beds 
and even phototherapy.
ConClUSIon
In the case report presented, a systemic cause 
of the development of porokeratosis was not 
found. Immune disorders as well as kidney failure 
were ruled out. This case of porokeratosis can 
therefore be classified as a sporadic case (26). 
The patient was advised to consistently use sun 
protection (UVA and UVB sunscreens), and peri-
odic dermatologic examinations were scheduled. 
The patient was followed up for two years without 
recurrence.
References
1.   Mibelli V. Contributo allo studio della iperche-
ratosi dei canali sudoriferi (porokeratosis). G 
Ital Mal Venerae Pelle 1893;28:313-35.
2.   Respighi E. Di una ipercheratosi non an-
cora descritta. G Ital Mal Venerae Pelle 
1893;28:356-86.
3.   Patrizi A, D’Acunto C, Passarini B, Neri I. 
Porokeratosis in the elderly: a new subtype of 
disseminated superficial actinic porokeratosis. 
Acta Dermatol Venereol 2000;80:302-4.
4.   Leow YH, Soon YH, Tham SN. Report of 31 
cases of porokeratosis at the National Skin Cen-
ter. Ann Acad Med Singapore 1996;25:837-41.
5.   Herranz P, Pizarro A, De Lucas R, Robayna 
MG, Rubio FA, Sanz A, et al. High incidence 
of porokeratosis in renal transplant recipients. 
Br J Dermatol 1997;136:176-9.
6.   Rodríguez EA, Jakubowicz S, Chinchilla DA, 
Carril A, Viglioglia PA. Porokeratosis of Mibelli 
and HIV-infection. J Dermatol 1996;35:402-4.
7.   Tsambaos D, Spiliopoulos T. Disseminated 
superficial porokeratosis: complete remission 
subsequent to discontinuation of immunosup-
pression. J Am Acad Dermatol 1993;28:651-2. 
8.   Otsuka F, Huang J, Samara K, Asahina A, Is-
hibashi Y. Disseminated porokeratosis accom-
panying multicentric Bowen’s disease. Cha-
racterization of porokeratotic lesions progres-
sing to Bowen’s disease. J Am Acad Dermatol 
1990;23:355-9. 
9.   Sasson M, Krain AD. Porokeratosis and cu-
taneous malignancy. A review. Dermatol Surg 
1996;22:339-42.
10. Schamroth JM, Zlotogorski A, Gilead L. Poro-
keratosis of Mibelli. Overview and review of the 
literature. Acta Derm Venereol 1997;77:207-
13.
11. Itoh M, Nakagawa H. Successful treatment 
of disseminated superficial actinic porokera-
tosis with Q-switched ruby laser. J Dermatol 
2007;34:816-20.
12. Carranza DC, Haley JC, Chiu M. Facial poro-
keratosis. Skinmed 2008;7:51-2.
13. Grover C, Goel A, Nanda S, Khurana N, Red-
dy BS. A case of extensive linear porokerato-
Figure 2. Multiple parakeratotic columns (cornoid lamel-
la) within the epidermis. In the upper malpighian layer, 
some of the keratinocytes are vacuolated and dyskera-
totic. A moderate focal lymphohistiocyte infiltrate and 
elastosis in the upper dermis. (HE stain, X40)
Štulhofer Buzina et al.      Acta Dermatovenerol Croat
Focal porokeratosis of nuchae  2010;18(4):257-260
260 ACTA DERMATOVENEROLOGICA CROATICA
sis with evaluation of topical tretinoin versus 
5-flourouracil as treatment modalities. J Der-
matol 2005;32:1000-4.
14. Danby W. Treatment of porokeratosis with flu-
orouracil and salicylic acid under occlusion. 
Dermatol Online J 2003;9:33.
15. Vlachou C, Kanelleas AI, Martin-Clavijo A, 
Berth-Jones J. Treatment of disseminated 
superficial actinic porokeratosis with topical 
diclofenac gel. J Eur Acad Dermatol Venereol 
2008;22:1343-5.
16. Ahn SJ, Lee HJ, Chang SE, Lee MW, Choi JH, 
Moon KC, Koh JK. Case of linear porokerato-
sis: successful treatment with topical 5% imi-
quimod cream. J Dermatol 2007;34:146-7.
17. Erbagci Z, Tuncel AA, Erbagci I. Successful 
treatment of porokeratosis with topical imiqui-
mod in 2 immunosuppressed cases. J Drugs 
Dermatol 2006;5:668-71.
18. Nayeemuddin FA, Wong M, Yell J, Rhodis E. 
Topical photodynamic therapy in dissemina-
ted actinic porokeratosis. Clin Exp Dermatol 
2002;27:703-6.
19. Danno K, Yamamoto M, Yokoo T, Ohta M, 
Ohno S. Etretinate treatment in disseminated 
porokeratosis. J Dermatol 1988;15:440-4.
20. De Simone C, Paradisi A, Massi G, Proietti H, 
Capponi A, Amerio PL, Capizzi R. Giant ver-
rucous porokeratosis of Mibelli mimicking pso-
riasis in a patient with psoriasis. J Am Acad 
Dermatol 2007;57:665-8.
21. Kanitakis J, Euvrard S, Faure M, Claudy A. 
Porokeratosis and immunosuppression. Eur J 
Dermatol 1998;8:459-65.
22. Zenarola P, Melillo L, Lomuto M, Carotenuto 
M, Gomes VE, Marzocchi W. Exacerbation of 
porokeratosis: a sign of immunodepression. J 
Am Acad Dermatol 1993;1035-6.
23. Lee HJ, Cho SB, Lee KH, Lee JH. A case 
of porokeratosis associated with chronic re-
nal failure. J Eur Acad Dermatol Venereol 
2006;20:1373-5.
24. Hernandez MH, Lai CH, Mallory SB. Dissemi-
nated porokeratosis associated with chronic 
renal failure: a new type of disseminated poro-
keratosis? Arch Dermatol 2000;136:1568-9.
25. Otsuka F, Someya T, Ishibashi Y. Porokerato-
sis and malignant skin tumors. J Cancer Res 
Clin Oncol 1991;117:55-60.
26. Malhotra SK, Puri KJ, Goyal T, Chahal KS. 
Linear porokeratosis. Dermatol Online J 
2007;13:15.
Štulhofer Buzina et al.      Acta Dermatovenerol Croat
Focal porokeratosis of nuchae  2010;18(4):257-260
erratum corrige
In Acta Dermatovenerologica Croatica Volume 18, Number 3 in the article ‘Expression of E-selectin 
in the skin of patients with atopic dermatitis: morphometric study’ by the error of authors instead of 
Gordana Gregorović name of Gordana Gregurek was printed.
